Publicacións en colaboración con investigadores/as de University of Texas MD Anderson Cancer Center (2)

2021

  1. Computational modeling identifies multitargeted kinase inhibitors as effective therapies for metastatic, castration-resistant prostate cancer

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 118, Núm. 40